Helicobacter Pylori Promotes the Expression of Krüppel-Like Factor 5, a Mediator of Carcinogenesis, In Vitro and In Vivo

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Noto, Jennifer M ^a   Khizanishvili, Tinatin ^a   Chaturvedi, Rupesh ^a   Piazuelo, M Blanca ^a   Romero Gallo, Judith ^a   Delgado, Alberto G ^a   Khurana, Shradha S ^b   Sierra, Johanna C ^a   Krishna, Uma S ^a   Suarez, Giovanni ^a   Powell, Anne E ^c   Goldenring, James R ^c   Coffey, Robert J ^a,c   Yang, Vincent W ^d   Correa, Pelayo ^a   Mills, Jason C ^b   Wilson, Keith T ^a,c,e   Peek, Richard M ^a,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d STONY BROOK UNIVERSITY   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KRUPPEL LIKE FACTOR 5; VACUOLATING TOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM MUTANT; CANCER GROWTH; COCULTURE; CONTROLLED STUDY; DYSPLASIA; EPITHELIUM CELL; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INTESTINE METAPLASIA; MALE; MOUSE; NONHUMAN; PATHOGENICITY ISLAND; PRECANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; STOMACH ADENOCARCINOMA; STOMACH BIOPSY; STOMACH CARCINOGENESIS; STOMACH EPITHELIUM; UPREGULATION; WILD TYPE;

EID: 84872784383     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054344     Document Type: Article

References (49)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Polk DB, Peek RM Jr, (2010) Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer 10: 403-414.
3. Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, et al. (2000) Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287: 1497-1500.
4. Sogawa K, Imataka H, Yamasaki Y, Kusume H, Abe H, et al. (1993) cDNA cloning and transcriptional properties of a novel GC box-binding protein, BTEB2. Nucleic Acids Res 21: 1527-1532.
5. Kojima S, Kobayashi A, Gotoh O, Ohkuma Y, Fujii-Kuriyama Y, et al. (1997) Transcriptional activation domain of human BTEB2, a GC box-binding factor. J Biochem 121: 389-396.
6. McConnell BB, Yang VW, (2010) Mammalian Krüppel-like factors in health and diseases. Physiolo Rev 90: 1337-1381.
7. Ohnishi S, Laub F, Matsumoto N, Asaka M, Ramirez F, et al. (2000) Developmental expression of the mouse gene coding for the Krüppel-like transcription factor KLF5. Dev Dyn 217: 421-429.
8. Sun R, Chen X, Yang VW, (2001) Intestinal-enriched Krüppel-like factor (Krüppel-like factor 5) is a positive regulator of cellular proliferation. J Biol Chem 276: 6897-6900.
9. Chanchevalap S, Nandan MO, Merlin D, Yang VW, (2004) All-trans retinoic acid inhibits proliferation of intestinal epithelial cells by inhibiting expression of the gene encoding Krüppel-like factor 5. FEBS Lett 578: 99-105.
10. Bateman NW, Tan D, Pestell RG, Black JD, Black AR, (2004) Intestinal tumor progression is associated with altered function of KLF5. J Biol Chem 279: 12093-12101.
11. Nandan MO, McConnell BB, Ghaleb AM, Bialkowska AB, Sheng H, et al. (2008) Krüppel-like factor 5 mediates cellular transformation during oncogenic KRAS-induced intestinal tumorigenesis. Gastroenterology 134: 120-130.
12. Nandan MO, Ghaleb AM, McConnell BB, Patel NV, Robine S, et al. (2010) Krüppel-like factor 5 is a crucial mediator of intestinal tumorigenesis in mice harboring combined ApcMin and KRASV12 mutations. Mol Cancer 9: 63.
13. McConnell BB, Klapproth JM, Sasaki M, Nandan MO, Yang VW, (2008) Krüppel-like factor 5 mediates transmissible murine colonic hyperplasia caused by Citrobacter rodentium infection. Gastroenterology 134: 1007-1016.
14. McConnell BB, Kim SS, Bialkowska AB, Yu K, Sitaraman SV, et al. (2011) Krüppel-like factor 5 protects against dextran sulfate sodium-induced colonic injury in mice by promoting epithelial repair. Gastroenterology 140: 540-549.
15. Tetreault MP, Alrabaa R, McGeehan M, Katz JP, (2012) Krüppel-like factor 5 protects against murine colitis and activates JAK-STAT signaling in vivo. PLoS ONE 7: e38338.
16. McConnell BB, Bialkowska AB, Nandan MO, Ghaleb AM, Gordon FJ, et al. (2009) Haploinsufficiency of Krüppel-like factor 5 rescues the tumor-initiating effect of the Apc(Min) mutation in the intestine. Cancer Res 69: 4125-4133.
17. McConnell BB, Kim SS, Yu K, Ghaleb AM, Takeda N, et al. (2011) Krüppel-like factor 5 is important for maintenance of crypt architecture and barrier function in mouse intestine. Gastroenterology 141: 1302-1313.
18. Franco AT, Israel DA, Washington MK, Krishna U, Fox JG, et al. (2005) Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc Natl Acad Sci U S A 102: 10646-10651.
19. Nagy TA, Frey MR, Yan F, Israel DA, Polk DB, et al. (2009) Helicobacter pylori regulates cellular migration and apoptosis by activation of phosphatidylinositol 3-kinase signaling. J Infect Dis 199: 641-651.
20. O'Brien DP, Romero-Gallo J, Schneider BG, Chaturvedi R, Delgado A, et al. (2008) Regulation of the Helicobacter pylori cellular receptor decay-accelerating factor. J Biol Chem 283: 23922-23930.
21. Barry DP, Asim M, Scull BP, Piazuelo MB, de Sablet T, et al. (2011) Cationic amino acid transporter 2 enhances innate immunity during Helicobacter pylori infection. PLoS ONE 6: e29046.
22. Nagy TA, Wroblewski LE, Wang D, Piazuelo MB, Delgado A, et al. (2011) beta-catenin and p120 mediate PPARdelta-dependent proliferation induced by Helicobacter pylori in human and rodent epithelia. Gastroenterology 141: 553-564.
23. Chaturvedi R, Asim M, Romero-Gallo J, Barry DP, Hoge S, et al. (2011) Spermine oxidase mediates the gastric cancer risk associated with Helicobacter pylori CagA. Gastroenterology 141: 1696-1708.
24. Powell AE, Wang Y, Li Y, Poulin EJ, Means AL, et al. (2012) The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor. Cell 149: 146-158.
25. Mera R, Fontham ET, Bravo LE, Bravo JC, Piazuelo MB, et al. (2005) Long term follow up of patients treated for Helicobacter pylori infection. Gut 54: 1536-1540.
26. Mills JC, Shivdasani RA, (2011) Gastric epithelial stem cells. Gastroenterology 140: 412-424.
27. Jensen KB, Watt FM, (2006) Single-cell expression profiling of human epidermal stem and transit-amplifying cells: Lrig1 is a regulator of stem cell quiescence. Proc Natl Acad Sci U S A 103: 11958-11963.
28. Nilsson J, Starefeldt A, Henriksson R, Hedman H, (2003) Lrig1 protein in human cells and tissues. Cell Tissue Res 312: 65-71.
29. Ghaleb AM, Nandan MO, Chanchevalap S, Dalton WB, Hisamuddin IM, et al. (2005) Krüppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation. Cell Res 15: 92-96.
30. McConnell BB, Ghaleb AM, Nandan MO, Yang VW, (2007) The diverse functions of Krüppel-like factors 4 and 5 in epithelial biology and pathobiology. BioEssays 29: 549-557.
31. Ghaleb AM, Yang VW, (2008) The pathobiology of Krüppel-like factors in colorectal cancer. Curr Colorectal Cancer Rep 4: 59-64.
32. Dong JT, Chen C, (2009) Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases. Cell Mol Life Sci 66: 2691-2706.
33. Yang Y, Goldstein BG, Nakagawa H, Katz JP, (2007) Krüppel-like factor 5 activates MEK/ERK signaling via EGFR in primary squamous epithelial cells. FASEB J 21: 543-550.
34. Chanchevalap S, Nandan MO, McConnell BB, Charrier L, Merlin D, et al. (2006) Krüppel-like factor 5 is an important mediator for lipopolysaccharide-induced proinflammatory response in intestinal epithelial cells. Nucleic Acids Res 34: 1216-1223.
35. Chen C, Bhalala HV, Qiao H, Dong JT, (2002) A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer. Oncogene 21: 6567-6572.
36. Liu R, Zheng HQ, Zhou Z, Dong JT, Chen C, (2009) KLF5 promotes breast cell survival partially through fibroblast growth factor-binding protein 1-pERK-mediated dual specificity MKP-1 protein phosphorylation and stabilization. J Biol Chem 284: 16791-16798.
37. Zheng HQ, Zhou Z, Huang J, Chaudhury L, Dong JT, et al. (2009) Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1. Oncogene 28: 3702-3713.
38. Tong D, Czerwenka K, Heinze G, Ryffel M, Schuster E, et al. (2006) Expression of KLF5 is a prognostic factor for disease-free survival and overall survival in patients with breast cancer. Clin Cancer Res 12: 2442-2448.
39. Dong JT, (2001) Chromosomal deletions and tumor suppressor genes in prostate cancer. Cancer Metastasis Rev 20: 173-193.
40. Chen C, Bhalala HV, Vessella RL, Dong JT, (2003) KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer. Prostate 55: 81-88.
41. Chaib H, Cockrell EK, Rubin MA, Macoska JA, (2001) Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA microarray analysis. Neoplasia 3: 43-52.
42. Jiang J, Chan YS, Loh YH, Cai J, Tong GQ, et al. (2008) A core KLF circuitry regulates self-renewal of embryonic stem cells. Nat Cell Biol 10: 353-360.
43. Nandan MO, Yang VW, (2009) The role of Krüppel-like factors in the reprogramming of somatic cells to induced pluripotent stem cells. Histol Histopathol 24: 1343-1355.
44. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
45. Takahashi K, Yamanaka S, (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
46. Parisi S, Passaro F, Aloia L, Manabe I, Nagai R, et al. (2008) KLF5 is involved in self-renewal of mouse embryonic stem cells. J Cell Sci 121: 2629-2634.
47. Ema M, Mori D, Niwa H, Hasegawa Y, Yamanaka Y, et al. (2008) Krüppel-like factor 5 is essential for blastocyst development and the normal self-renewal of mouse ESCs. Cell Stem Cell 3: 555-567.
48. Wong VW, Stange DE, Page ME, Buczacki S, Wabik A, et al. (2012) Lrig1 controls intestinal stem-cell homeostasis by negative regulation of ErbB signalling. Nat Cell Biol 14: 401-408.
49. Hedman H, Henriksson R, (2007) Lrig inhibitors of growth factor signalling- double-edged swords in human cancer? Eur J Cancer 43: 676-682.